5-oxo-prolyl-glycyl-arginine-4-nitroanilide has been researched along with cyanogen bromide in 1 studies
| Studies (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Trials (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Recent Studies (post-2010) (5-oxo-prolyl-glycyl-arginine-4-nitroanilide) | Studies (cyanogen bromide) | Trials (cyanogen bromide) | Recent Studies (post-2010) (cyanogen bromide) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 4,370 | 2 | 41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boutaud, A; Castellino, FJ | 1 |
1 other study(ies) available for 5-oxo-prolyl-glycyl-arginine-4-nitroanilide and cyanogen bromide
| Article | Year |
|---|---|
The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Topics: Aminocaproic Acid; Base Sequence; Binding Sites; Cell Line; Cyanogen Bromide; Enzyme Activation; Fibrin; Fibrinogen; Gene Expression; Humans; Kidney; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Plasminogen; Recombinant Fusion Proteins; Substrate Specificity; Urokinase-Type Plasminogen Activator | 1993 |